4,029 Shares in The Ensign Group, Inc. $ENSG Purchased by Calamos Advisors LLC

Calamos Advisors LLC purchased a new position in shares of The Ensign Group, Inc. (NASDAQ:ENSG) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 4,029 shares of the company’s stock, valued at approximately $812,000.

A number of other institutional investors also recently added to or reduced their stakes in the stock. Parkside Financial Bank & Trust grew its stake in shares of The Ensign Group by 2.9% in the 4th quarter. Parkside Financial Bank & Trust now owns 2,000 shares of the company’s stock valued at $348,000 after purchasing an additional 57 shares during the period. Csenge Advisory Group lifted its position in shares of The Ensign Group by 3.7% during the 4th quarter. Csenge Advisory Group now owns 1,642 shares of the company’s stock worth $286,000 after buying an additional 58 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its position in shares of The Ensign Group by 0.4% during the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 14,451 shares of the company’s stock worth $2,912,000 after buying an additional 58 shares during the period. Northwestern Mutual Wealth Management Co. boosted its stake in The Ensign Group by 55.0% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 172 shares of the company’s stock valued at $30,000 after buying an additional 61 shares in the last quarter. Finally, Envestnet Portfolio Solutions Inc. grew its position in The Ensign Group by 2.9% in the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 2,189 shares of the company’s stock valued at $381,000 after acquiring an additional 62 shares during the period. 96.12% of the stock is owned by institutional investors and hedge funds.

The Ensign Group Stock Performance

Shares of NASDAQ:ENSG opened at $172.89 on Friday. The company has a current ratio of 1.56, a quick ratio of 1.56 and a debt-to-equity ratio of 0.06. The Ensign Group, Inc. has a 1-year low of $134.79 and a 1-year high of $218.00. The stock has a market capitalization of $10.10 billion, a P/E ratio of 28.16, a P/E/G ratio of 1.64 and a beta of 0.69. The business has a 50-day moving average price of $165.86 and a two-hundred day moving average price of $184.10.

The Ensign Group (NASDAQ:ENSG) last issued its earnings results on Thursday, April 30th. The company reported $1.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.79 by $0.06. The Ensign Group had a net margin of 6.89% and a return on equity of 16.78%. The company had revenue of $1.39 billion for the quarter, compared to analyst estimates of $1.40 billion. During the same quarter last year, the firm earned $1.52 EPS. The company’s revenue for the quarter was up 18.4% on a year-over-year basis. The Ensign Group has set its FY 2026 guidance at 7.480-7.620 EPS. Equities analysts predict that The Ensign Group, Inc. will post 6.82 earnings per share for the current year.

The Ensign Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be issued a $0.065 dividend. This represents a $0.26 annualized dividend and a yield of 0.2%. The ex-dividend date is Tuesday, June 30th. The Ensign Group’s dividend payout ratio is currently 4.23%.

Insider Buying and Selling

In other The Ensign Group news, Director John O. Agwunobi sold 392 shares of the company’s stock in a transaction on Monday, April 20th. The shares were sold at an average price of $199.97, for a total transaction of $78,388.24. Following the completion of the sale, the director owned 9,295 shares in the company, valued at approximately $1,858,721.15. The trade was a 4.05% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Barry M. Smith sold 700 shares of the company’s stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $164.28, for a total transaction of $114,996.00. Following the sale, the director owned 21,352 shares of the company’s stock, valued at $3,507,706.56. The trade was a 3.17% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 1,792 shares of company stock worth $320,931. Insiders own 4.00% of the company’s stock.

Wall Street Analysts Forecast Growth

ENSG has been the subject of several recent analyst reports. Weiss Ratings lowered The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a research note on Tuesday, June 16th. Zacks Research cut The Ensign Group from a “strong-buy” rating to a “hold” rating in a report on Monday, April 6th. Royal Bank Of Canada restated an “outperform” rating on shares of The Ensign Group in a research note on Tuesday, June 9th. Wall Street Zen raised shares of The Ensign Group from a “hold” rating to a “buy” rating in a report on Sunday, June 14th. Finally, Truist Financial dropped their target price on shares of The Ensign Group from $215.00 to $202.00 and set a “hold” rating for the company in a research report on Tuesday. Four analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $213.50.

About The Ensign Group

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.